AAAAAA
Results:
1-15
|
Results: 15
Authors:
MOZES E
ZINGER H
KOHN LD
SINGER DS
Citation: E. Mozes et al., SPONTANEOUS AUTOIMMUNE-DISEASE IN (NZB X NZW)F-1 MICE IS AMELIORATED BY TREATMENT WITH METHIMAZOLE, Journal of clinical immunology, 18(2), 1998, pp. 106-113
Authors:
STHOEGER ZM
ZINGER H
MOZZES E
Citation: Zm. Sthoeger et al., THE BENEFICIAL-EFFECTS OF THE ANTIESTROGEN TAMOXIFEN ON SYSTEMIC LUPUS-ERYTHEMATOSUS OF (NZBXNZW)F1 MICE ARE ASSOCIATED WITH SPECIFIC REDUCTION OF IGG3 AUTOANTIBODIES, Arthritis and rheumatism, 41(9), 1998, pp. 864-864
Authors:
MOZES E
ALLING D
MILLER MW
PAYNE SM
ZINGER H
VIA CS
SHEARER GM
Citation: E. Mozes et al., GENETIC-ANALYSIS OF EXPERIMENTALLY-INDUCED LUPUS IN MICE, Clinical immunology and immunopathology, 85(1), 1997, pp. 28-34
Authors:
WAISMAN A
RUIZ PJ
ISRAELI E
EILAT E
KONENWAISMAN S
ZINGER H
DAYAN M
MOZES E
Citation: A. Waisman et al., MODULATION OF MURINE SYSTEMIC LUPUS-ERYTHEMATOSUS WITH PEPTIDES BASEDON COMPLEMENTARITY-DETERMINING REGIONS OF A PATHOGENIC ANTI-DNA MONOCLONAL-ANTIBODY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(9), 1997, pp. 4620-4625
Authors:
DAYAN M
ZINGER H
KALUSH F
MOR G
AMIRZALTZMAN Y
KOHEN F
STHOEGER Z
MOZES E
Citation: M. Dayan et al., THE BENEFICIAL-EFFECTS OF TREATMENT WITH TAMOXIFEN AND ANTI-ESTRADIOLANTIBODY ON EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS ARE ASSOCIATED WITH CYTOKINE MODULATIONS, Immunology, 90(1), 1997, pp. 101-108
Authors:
MOZES E
SEGAL R
STHOEGER Z
DAYAN M
ZINGER H
KOHN LD
SINGER DS
Citation: E. Mozes et al., MODULATION OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS, Israel journal of medical sciences, 32(1), 1996, pp. 19-21
Authors:
RUIZ PJ
ZINGER H
MOZES E
Citation: Pj. Ruiz et al., EFFECT OF INJECTION OF ANTI-CD4 AND ANTI-CD8 MONOCLONAL-ANTIBODIES ONTHE DEVELOPMENT OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IN MICE, Cellular immunology, 167(1), 1996, pp. 30-37
Authors:
SEGAL R
DAYAN M
ZINGER H
MOZES E
Citation: R. Segal et al., METHOTREXATE TREATMENT IN MURINE EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - CLINICAL BENEFITS ASSOCIATED WITH CYTOKINE MANIPULATION, Clinical and experimental immunology, 101(1), 1995, pp. 66-72
Authors:
LEVITE M
ZINGER H
ZISMAN E
REISNER Y
MOZES E
Citation: M. Levite et al., BENEFICIAL-EFFECTS OF BONE-MARROW TRANSPLANTATION ON THE SEROLOGICAL MANIFESTATIONS AND KIDNEY PATHOLOGY OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS, Cellular immunology, 162(1), 1995, pp. 138-145
Authors:
SEGAL R
GLOBERSON A
ZINGER H
MOZES E
Citation: R. Segal et al., INHIBITION OF AUTOANTIBODY PRODUCTION IN EXPERIMENTAL SLE BY PREIMMUNIZATION WITH DNA, Autoimmunity, 17(2), 1994, pp. 149-156
Authors:
STHOEGER ZM
BENTWICH Z
ZINGER H
MOZES E
Citation: Zm. Sthoeger et al., THE BENEFICIAL EFFECT OF THE ESTROGEN ANTAGONIST, TAMOXIFEN, ON EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS, Journal of rheumatology, 21(12), 1994, pp. 2231-2238
Authors:
RUIZ PJ
ZINGER H
MOZES E
Citation: Pj. Ruiz et al., INDUCTION OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IN MICE BY IMMUNIZATION WITH THE F(AB')(2)-FRAGMENT OF THE HUMAN ANTI-DNA MONOCLONAL-ANTIBODY CARRYING THE 16 6-IDIOTYPE/, Immunology letters, 41(1), 1994, pp. 79-84
Authors:
SINGER DS
KOHN LD
ZINGER H
MOZES E
Citation: Ds. Singer et al., METHIMAZOLE PREVENTS INDUCTION OF EXPERIMENTAL SYSTEMIC LUPUS-ERYTHEMATOSUS IN MICE, The Journal of immunology, 153(2), 1994, pp. 873-880
Authors:
WAISMAN A
MENDLOVIC S
RUIZ PJ
ZINGER H
MESHORER A
MOZES E
Citation: A. Waisman et al., THE ROLE OF THE 16 6 IDIOTYPE NETWORK IN THE INDUCTION AND MANIFESTATIONS OF SYSTEMIC LUPUS-ERYTHEMATOSUS/, International immunology, 5(10), 1993, pp. 1293-1300
Authors:
LEVITE M
ZINGER H
MOZES E
REISNER Y
Citation: M. Levite et al., SYSTEMIC LUPUS ERYTHEMATOSUS-RELATED AUTOANTIBODY PRODUCTION IN MICE IS DETERMINED BY BONE-MARROW-DERIVED CELLS, Bone marrow transplantation, 12(3), 1993, pp. 179-183
Risultati:
1-15
|